Exposure to low doses of radiation has been recently proven to be much more mutagenic and carcinogenic than previously thought. Since radiation sensitivity varies with different phases of cell cycle, we have investigated the activation of protein kinase C (PKC) after low doses (0.10-1 Gy) of γ-irradiation on proliferating (log) and non-proliferating (confluent/plateau) human normal lung fibroblast (MRC-5) cells. PKC isoforms have been shown to play key roles in the regulation of proliferation, differentiation, migration and survival. In this study, we have examined the activation of phosphorylated forms of PKC isoforms (PKC-βII, PKC-α/β, PKC-θ) and non-phosphorylated PKC-α in an attempt to understand its kinases in total and subcellular (cytosolic and nuclear) fractions. Cytosolic fraction of the log phase cells showed an increase in activity of PKC-βII, PKC-α/β and PKC-θ with the radiation dose. However, in the nuclear fraction, PKC-βII and PKC-θ showed higher activity than the PKC-α/β. In the plateau phase cells of the cytosolic fraction, PKC-βII showed higher activity than the PKC-α/β and PKC-θ isoforms. Furthermore, in the nuclear fraction PKC-βII and PKC-α/β isoforms showed higher activity than the PKC-θ. In total cellular protein of the log phase cells, a dose dependent increase in PKC-βII activity followed by PKC-α/β was observed and in the plateau phase of cells, PKC-βII showed higher activity than the PKC-α/β. The specific activation of PKC isoforms in the plateau phase cells, as demonstrated for the first time, may help us to understand the radiation induced initiation of cellular transformation like hyper-proliferative phenotype, if any.
INTRODUCTION
All humans receive some radiation exposure and there are considerable concerns prevail about the detrimental health effects associated with the low doses of radiation exposure. 1, 2) At doses above 50 mSv, radiation-induced cancer risk can be estimated based on the cancer incidence among the atomic bomb survivors. 3, 4) However, exposure to low doses of ionising radiation and its cellular alterations leading to various health effects are not fully established. Ionising radiation induces single strand breaks, double strand breaks (DSBs) and hence damage the cellular responses of the genome. [5] [6] [7] [8] The cellular effects of radiation on genes involved in growth suppressive and DNA repair activities are well reported 2, 9) and the established dogma has relied on the assumption that DNA of the nucleus is the main target for radiation-induced genotoxicity and carcinogenesis. Parallel to various transcriptional activation mediated by DNA, radiation induced changes in signalling pathways initiated at cellular levels are not well understood. The kinetics of the responses appears to vary with radiation dose, quality (low and high-linear energy transfer, LET), phases in cell cycle and cell type. Though it is known that radiation alters the genome of the normal proliferating cell(s) to become cancerous, however, the mechanisms involved after the low doses of radiation on the normal non-proliferating cells are poorly understood. Radiation causes injury to normal tissue(s) by cell killing, alters cell-to-cell communication and inflammatory responses, compensatory tissue hypertrophy of remaining normal tissue and tissue repair processes. 10) It is established that cancer arises in a multistep fashion and the environmental exposures to physical and chemical agents are major etiological factors. 11) Signalling cascades can affect cellular growth, differentiation and cell survival, which also mediates cellular responses to various physiological and environmental stimuli. Activation of protein kinase C (PKC) is an early event in cell signaling leading to a variety of cellular responses. 12) PKC, a ubiquitous, phospholipids dependent enzyme is involved in radiation-induced cell proliferation, 13) differentiation 14) and apoptosis. [15] [16] [17] [18] Thus, radiation-induced activation of PKC occurs in many mammalian cells, there are considerable concerns prevails about the detrimental health effects associated with the low doses of radiation exposure on the activation of signaling cascades like PKC and mitogen-activated protein kinase (MAPK). 5, 19, 20) Since radiation sensitivity varies with different phases of cell cycle, in the present study, we have used both proliferating (log) and non-proliferating (confluent/plateau) human normal lung fibroblast (MRC-5) cells to study its sensitivity to the low doses of γ-irradiation. In a preliminary study, we have analysed seven PKC isoforms which are involved in cell cycle, proliferation and cell death of human normal lung fibroblast cells (MRC-5): among them, three isoforms (PKC-βII, PKC-α/β, PKC-θ) were activated with the radiation dose. In the present study, we demonstrate that the activation of PKC isoforms in subcellular (cytosolic and nuclear) fractions and also in total cellular responses in log and plateau phases of human normal lung fibroblast cells after low doses (0.10 -1 Gy) of γ-irradiation.
MATERIALS AND METHODS

Cell culture
Human normal lung fibroblast (MRC-5) cells were obtained from Coriell Cell Repository (Camden, NJ, USA). Cells were maintained in Eagle's minimal essential medium (MEM) supplemented with 15% foetal bovine serum, vitamins, essential amino acids, non-essential amino acids and antibiotics. All reagents were obtained from GIBCO, Carlsbad, CA, USA. Cells were maintained at 37°C in a humidified 5% CO2 atmosphere as described previously. 21) The medium was changed every 3 days and the cells were passed at confluence.
Gamma Irradiation
Proliferating (log phase) MRC-5 cells grown to 70-75% and cells synchronized at G0/G1 phase by growing them to confluence (plateau phase) were used. For the plateau phase study, MRC-5 cells synchronized by growing them to confluence and maintained in that state for a week with a change of medium every 3 days were used. 21) Cells rest in this stage (G0) a week or two and can be grown normal 22) when plated into new culture flasks. Cells were irradiated with different doses (0.10 to 1 Gy) of γ-rays using 137 Cs source at a dose rate of 0.98 Gy/min. 23) At least three independent experiments were performed for each treatment. For protein analysis, cells were harvested 30 min after irradiation and this time interval was selected from our earlier study to analyse the PKC activity.
23)
Cell viability assay
Short and long-term cell survival was determined by both trypan blue exclusion and also colony-forming assays as described by Baskar et al.. 22, 24) For the short-term cell survival assay (trypan blue exclusion), cells were plated in T-25 flasks for 24 h after which, cells were irradiated to 0.50, 0.75 and 1 Gy. Incubations carried out at 37°C for different time periods. At 12, 24 and 48 h after irradiation, cells were harvested and incubated with 0.4% w/v trypan blue solution (Sigma-Aldrich, USA) for 5 min. Cell viability was determined by trypan blue exclusion assay using a hemocytometer. The percentage cell survival for each treatment group was determined by counting the dead cells (blue) and the live cells (clear). Data are expressed as percentage of control living cells. For the long-term cell survival assay (colony formation), MRC-5 cells were seeded at a density of 700 cells/6 cm dishes at 24 h prior to the radiation (0.10, 0.25, 0.50, 0.75 and 1 Gy) exposure. Cells were grown for ~10 days at 37°C in a humidified 5% CO2 atmosphere with complete medium. The colonies were fixed with 70% ethanol and stained with coomassie brilliant blue (Merck, Darmstadt, Germany). Clones were counted and expressed as the percent of control survival. For colony formation study, cells in triplicates were performed and the results are presented as mean values of triplicate ± standard error of the mean (SEM).
Measurement of cell cycle distribution
For cell cycle analysis, proliferating and confluent MRC-5 cells cultured in 75 cm 2 tissue culture flask (T-75, Nunc, Roskilde, Denmark) were used. Cells were trypsinised, washed once in phosphate-buffered saline and fixed in ice cold 70% ethanol overnight at 4°C. Cells were then mixed with 0.5 ml of propidium iodide (PI) solution (10 mM TrisHCl, 0.7 mg of RNase per ml, 10% NP-40, 1 M NaCl, 0.05 mg/ml of PI) and incubated for 30 min at 4°C. Cells were analysed with a FACS Calibre System (Becton Dickinson, Heidelberg, Germany) flow cytometer and 10,000 events were recorded. Cell cycle profiles were generated by Cell Quest software.
Preparation of protein extracts: Total cell extracts
Total cellular proteins were isolated 30 min after irradiation as described earlier 21, 24) using RIPA (radioimmunoprecipitation assay) buffer (1% w/v Nonidet P-40, 1% w/v sodium deoxycholate, 0.1% w/v SDS, 0.15 M NaCl, 0.01 M sodium phosphate, 2 mM EDTA, 50 mM sodium fluoride, 0.2 mM sodium vanadate and 100 U/ml aprotinin, pH 7.2). Proteins were recovered by centrifugation at 14,000 rpm for 10 min. Protein concentration was determined by the bicinchoninic acid (BCA) method using an assay kit (Pierce Biotechnology, Rockford, IL, USA) with bovine serum albumin as a standard.
Preparation of cellular fractions
Cytosolic and nuclear fraction proteins were isolated 30 min after irradiation following the method of Baskar et al.. 23) Cells were lysed for 8 min on ice in 400 μl of hypotonic buffer containing 0.5% Nonidet p-40. The cell lysates were centrifuged at 3000 rpm for 5 min and the cytoplasmic proteins (supernatant) were transferred to a fresh tube. The cell pellet fraction containing the detergent nuclear proteins was lysed for 20 min with 200 μl of 20 mM sodium phosphate buffer (pH 8.0) containing 0.5 M NaCl, 1 mM EDTA, 0.75% Triton X-100, 10% glycerol, 5 mM MgCl 2 and 1 mM PMSF. The proteins were recovered by centrifugation at 12,000 rpm for 5 min. Protein concentration was determined by the BCA method as explained above.
SDS-PAGE and Western blot analysis
Western blot analysis was done as previously described. 23, 24) Protein expression of phosphorylated forms of PKC-βII (phospho PKC -pan-antibody, #9371, kDa-78), PKC-α/βII (phospho-PKC-α/βII antibody, #9375, kDa-80), PKC-θ (phospho-PKC-θ antibody, #9377, kDa-79) and nonphosphorylated PKC-α (PKC-α antibody, #2056, kDa-80) (Cell Signalling Technology, Carlsbad, CA, USA), PKC (α, β, γ antibodies in one clone, clone M110, #P17252, kDa-80, Millipore, Billerica, MA, USA) and actin (SC-1616, kDa-43, Santa Cruz Biotechnology, Santa Cruz, CA, USA) were analysed using specific antibodies. Equal amounts of cell lysates were fractionated using 4-20% polyacrylamide gradient gel electrophoresis and blotted onto polyvinylidene fluoride (PVDF) membranes using the manufacturer's standard protocol (Invitrogen Corporation, Carlsbad, CA, USA). The membranes were immersed in TBST (20 mM Tris-HCl, pH 7.4, 137 mM NaCl, 0.2% Tween) buffer containing 5% non-fat dried milk (NFDM) for 60 min at room temperature. Membranes were then incubated with the primary antibody at 1:1000 dilutions in TBST-5% NFDM overnight and thereafter washed three times (5 min each) in TBST buffer. Membranes were then incubated with horseradish peroxidase conjugated secondary antibodies (1:2000 dilutions in TBST-5% NFDM, Vector Laboratories, Burlingame, CA, USA) for 1 h followed by repeated washing in TBST buffer. The protein signal was detected by chemiluminescence following the manufacturer's protocol (Pierce Biotechnology, Rockford, IL, USA). The densities of the bands were quantified using Kodak 1D image analysis software (Kodak, Rochester, NY, USA).
Statistical analysis
All values are expressed as mean ± SEM. Each value is the mean of at least three separate experiments. Significant differences between test and control data were analysed by one-way ANOVA followed by Tukey's multiple comparison tests. A value of p < 0.05 was considered statistically significant.
RESULTS
Cell survival and Cell cycle analysis
We first analysed the radiation sensitivity of MRC-5 cells by both trypan blue exclusion (short term cell survival) assay and also colony-forming (long term cell survival) assay. MRC-5 cells were harvested at 24, 48 and 72 h after irradiation to 0.50-1 Gy and cell viability was assessed using the trypan blue exclusion assay. No significant cell loss was detected in the MRC-5 cells harvested at 24 and 48 h after irradiation. In contrast, cells irradiated to 0.75 (79.92%, p < 0.05) and 1 Gy (74.29%, p < 0.05) showed increase in cell death at 72 h, i.e. reduced cell survival (Fig. 1A) . In the colony formation assay, dose-dependent decrease in cell survival (0.10 Gy-97.4%; 0.25 Gy-95.9%; 0.50 Gy-91.3%, 0.75 Gy-82.3% and 1 Gy-75.7%) was observed (Fig. 1B) and this effect was more pronounced at higher doses (0.75 and 1 Gy, p < 0.05). Since cellular sensitivity vary at different Fig. 1 . Survival of MRC-5 cells after low doses of gamma irradiation were studied using A. trypan blue dye exclusion assay (for short-term cell survival) and B. colony formation assay (for longterm cell survival). For the trypan blue exclusion, cells were plated in T-25 flasks for 24 h prior to irradiation (0.50, 0.75 and 1 Gy). At 12, 24 and 48 h after irradiation, cell viability was determined by trypan blue exclusion assay using a hemocytometer. The percentage cell survival for each treatment group was determined by counting the dead cells (blue) and the live cells (clear). For the colony formation assay, cells were seeded at a density of 700 cells/ 6 cm dishes at 24 h prior to the radiation (0.10, 0.25, 0.50, 0.75 and 1 Gy) exposure. Cells were grown for two weeks at 37°C in a humidified 5% CO2 atmosphere with complete medium. The surviving colonies were fixed in 70% ethanol. Colonies were stained with coomassie brilliant blue solution. Clones were counted and expressed as the percent of control survival. All doses were assayed in triplicate. Data represent the mean ± SEM of three independent experiments. *P < 0.05 compared with control. phases of the cell cycle, we used proliferating (log) and confluent (plateau) phases of MRC-5 cells to study the effects of low doses of γ-irradiation. Cell cycle analysis of the proliferating cells showed 67.95% and 32.05% cells in G 0 /G 1 phase and in S-G 2 /M phases, respectively ( Fig. 2A) . In confluent cells, 95.73% in G 0 /G 1 phase and 4.27% of cells were in S and G 2 /M phases (Fig. 2B) .
We next examined the subcellular distribution of phosphorylated PKC isoforms (βII, α/β and θ) and nonphosphorylated PKC-α in log and plateau phases of MRC-5 cells using specific antibodies after 30 min of irradiation. A cell fraction procedure was adopted to examine the phosphorylated PKC isoforms in both cytosolic and nuclear protein fractions. As phosphorylation reflects kinase activity, term "activation" was used throughout the manuscript for the increased level of PKC isoforms in the irradiated cells.
Phosphorylated PKC isoforms in the subcellular log phase cells
In the cytosolic fraction of the proliferating cells, PKC-βII, α/β and PKC-θ showed a dose dependent increase in the activity (Figs. 3A & B) . Among the 3 isoforms, PKC-βII showed higher activity. In the nuclear fraction, PKC-βII and PKC-θ displayed a higher activity than the PKC-α/β (Figs. 3C & D) . In contrast to the non-irradiated respective (cytosolic and nuclear) control cells, PKC-βII and PKC-θ showed higher activity in the nuclear fraction (PKC-βII, 1 Gy-6.3 fold, p < 0.05; PKC-θ, 1 Gy-5.9 fold, p < 0.05) and also in the cytosolic fraction (PKC-βII, 1 Gy-4.5 fold, p < 0.05 and PKC-θ, 1 Gy-3.9 fold, p < 0.05). PKC-α/β did not show any significant increase in the nuclear fraction, whereas a significant increase (0.75 Gy-3.1 fold, p < 0.05 and 1 Gy-3.8 fold, p < 0.05) in cytosolic fraction was observed when compared with their respective non-irradiated control cell fractions (cytosolic fraction). 
Phosphorylated PKC isoforms in subcellular plateau phase cells
Cytosolic fraction of the confluent cells showed an increase in all the three PKC isoforms (βII, α/β and θ) with the radiation dose. However, PKC-βII exhibited higher activity than the PKC-α/β and PKC-θ isoforms (Figs. 4A &  B) . In the cytosolic fraction, PKC-βII showed higher activation after exposure to 0.50 Gy (2.3 fold, p < 0.05), 0.75 Gy (2.6 fold, p < 0.05) and 1 Gy (2.8 fold, p < 0.05). Increased level of PKC-α/β was seen only after exposure to 1 Gy (2.2 fold, p < 0.05), whereas PKC-θ showed increase in activity after exposure to 0.75 Gy (2.3 fold, p < 0.05) and 1 Gy (2.7 fold, p < 0.05). In the nuclear fraction a dose dependent increase in PKC-βII and PKC-α/β was evident and this was significant after exposure to 0.50 (3, 3.6 fold respectively, p < 0.05), 0.75 (3, 4.2 fold respectively, p < 0.05) and 1 Gy (3.2, 5.5 fold respectively, p < 0.05) (Figs. 4C & D) . There was no significant increase in PKC-θ activity in the nuclear fraction.
Total cellular proteins
An enhanced and specific activation of phosphorylated PKC isoforms in subcellular fractions of log and plateau phases of cells prompted us to verify whether or not the increase in phosphorylated forms of PKC is reflected in the total cellular proteins. Proteins isolated from the irradiated (0.10, 0.20, 0.50 and 1 Gy) log and plateau phases of cells were immunoreacted with the phosphorylated PKC-βII and PKC-α/β (Figs. 5A-D) . PKC-βII and PKC-α/β isoforms showed higher activity in the subcellular (cytosolic and nuclear) protein fractions were selected to study further in the total cellular proteins. Higher activation of phosphorylated forms of PKC-βII was seen in the log phase cells after exposure to 0.50 Gy (3.1 fold, p < 0.05) and 1 Gy (5.6 fold, p < 0.05) (Figs. 5A & B) . However, a dose dependent increase in PKC-α/β activity was seen with the radiation dose and this was only significant after exposure to 1 Gy (2.9 fold, p < 0.05). In the plateau phase cells, the lowest radiation dose 0.10 Gy did not show any increase in PKC-βII or PKC-α/β activity (Figs. 5C & D) . However, a higher activity was evident from 0.20 Gy onwards. Only PKC-βII showed two fold (p < 0.05) increase after 1 Gy of irradiation than the non-irradiated control cells. An enhanced and specific activation of phosphorylated PKC isoforms after 30 minutes of irradiation in the log and plateau phases of cells prompted us to study the non-phosphorylated protein level. Proteins isolated from the cells irradiated to 0.10, 0.50 or 1 Gy were immunoreacted with non-phosphorylated PKC-α. In the present study, we have investigated only one non-phosphorylated PKC i.e. PKC-α, which did not show any higher activation than the Fig. 4 . Changes in the levels of phosphroylated forms of PKC isoforms in the confluent (plateau phase) cells, 30 min after irradiation. Cytosolic (A) and nuclear (C) fraction proteins were isolated. Equal amounts of proteins were separated using 4-20% SDS-PAGE, transferred to PVDF membrane and immunoreacted with antibodies against phosphorylated PKC isoforms (PKC-βII, PKC-α/β, PKC-θ). B&D-Numbers indicate the fold increases in level of PKC isoforms over control. Actin was used as a loading control.
control cells (Figs. 6A & B) . However, when studied at 4 h after irradiation (0.50-1 Gy) only proliferating cells showed an increase (0.75 and 1 Gy, p < 0.05) in total PKC level (Figs. 7A & B) .
DISCUSSION
In the present study, we have evaluated the subcellular effects of low dose radiation on the activation of protein kinase C (PKC) in proliferating and confluent human normal lung fibroblasts cells. The biological and health effects from the low doses of radiation exposures have been recently proven to be much more mutagenic and carcinogenic. 9, 25, 26) The available data on risks associated with radiation exposure come from people exposed to radiation from the epidemiological studies of Japanese A-bomb, Chernobyl accident survivors and also clinically exposed survivors. [27] [28] [29] [30] [31] Radiation induced DNA damage and its manifestations on the genomic instability are well-reported. [32] [33] [34] [35] Radiation sensitivity varies with different phases of the cell cycle and it is known that the normal proliferating cells are radiosensitive, though the mutated cancer cells are not. PKC regulates radiation induced TPA (12-O-tetradecanoylphorbol-13-acetate) mediated cell transformations, 14) mediates radiosensitivity, 13) apoptosis and survival in diverse cellular systems. [15] [16] [17] PKC translocates to different subcellular sites in response to various stress stimuli. However, the role of its subcellular localization after low dose of radiation remains largely unknown. Understanding the biological functions of the individual PKC isoforms and the cellular pathways in which they participate in the radiation-induced transformation of the normal cells is of great importance. It is known that the proliferating cells with different phases in cell cycle are radiosensitive than the non-proliferating cells. Since radiation sensitivity varies with different phases of the cell cycle, in the present study, we have used the synchronised MRC-5 cells by growing them to confluence (G0/G1 phase) and radiation induced activation of PKC was investigated 30 min after irradiation in both the proliferating and also in the G0/G1 (non-proliferating) cells.
PKC is a family of serine/threonine kinases, which plays a central regulatory role in cell cycle progression, differentiation, apoptosis, cytoskeletal remodelling, modulation of ion channels and secretion. 36, 37) PKC isoforms (~12) have distinct functions in cellular growth and differentiation. 12, 38) Inhibition of PKC leads to increased sensitivity of cells to ionising radiation suggesting its importance in cellular response to radiation. 39) In the present study, no cell death was observed after 30 min of post irradiation, therefore we have selected this earlier time point to study the effect on the signaling cascades involved. Our data demonstrates that the low doses of γ-irradiation activated phosphorylated forms of PKC isoforms in log and plateau phase cells in nucleus and cytoplasm of the normal human lung fibroblast cells. In the resting control cells, PKCs are predominately localized in the cytosol, 40) whereas in the present study upon activation by radiation, PKC isotype-specific signals might have triggered the translocation from the cytosol to the nuleoplasm. Plateau phase of normal human lung fibroblast cells can replicate when replated in a fresh tissue culture flask. We showed for the first time that the PKC could be activated by low doses of radiation even at the G0/G1 (log) stage of the cells.
PKC isoforms (~12) have distinct functions in cellular growth and differentiation. Activation of PKC is known to change the subcellular location of its isoforms. 41) In the present study, phosphorylated PKC isoforms were activated at 30 min after irradiation. Moreover, metabolically-notactive plateau phase of cells also showed elevated levels of PKC in nucleoplasm in addition to the cytoplasm cell fractions. Although specific functions of individual PKC isoforms are not clearly established after radiation exposure, reports using a variety of pharmacological and molecular approaches showed a role of PKC family in the regulation of cell growth. 37, 42, 43) In the present study, PKC-βII showed higher activation in both the fractions of log and plateau phases of cells. Earlier studies have suggested a role of PKC isoforms in tumour promotion and increased levels of PKC have been associated with malignant transformation in a number of cell lines including breast, 44) lung 45) and gastric cancers. 46) In total cellular protein of the log phase cells, a dose dependent increase in PKC-βII followed by PKC-α/β was observed. However, in the plateau phase cells, only PKC-βII showed higher activity than the PKC-α/β. We assume that these proteins are shuttling when the cells are stressed by the low doses of radiation exposures, indicating sensitivity of the subcellular fractions than the total cell study. A recent study showed that the large genome rearrangements are also can occur in the non-dividing mammalian cells. 47) Using higher radiation doses (< 10 Gy) it was shown that γ-irradiation induced apoptosis, growth arrest and contractile dysfunction of the visceral smooth muscle cells of guinea pig via the activation and translocation of PKC-α and PKC-ε isoforms from the cytoplasm to the nucleus. 48) In view of the observed γ-radiation-induced PKC activation, the use of PKC inhibitors to amend radiation-induced fibroblast cells proliferation may warrant further examination. The PKC family is a target for therapeutic intervention for its role in tumourigenesis and the present results indicate that PKC family may act as a damage recognition molecule in activating proteins involved in cell cycle and death for e.g. p53 and cyclin dependent kinase inhibitor p21, (data not shown) after low doses of γ-irradiation on the human normal lung fibroblast cells. For example, elevated expression of PKC-βII is an early promotive event in colon carcinogenesis. 49) In conclusion, a better understanding of the detrimental health effects associated with the low doses of radiation exposure is critical for modulation and evaluation of protocols to improve the efficacy of treatments. The activation of phosphorylated PKC in the plateau phase of the human normal lung fibroblast cells suggests that the induction of signalling cascades can occur even in the absence of active cellular proliferation. PKC functions are regulated by the cofactors, translocation and phosphorylation. Identification of this critical pathway may help us to understand the molecular basis for the initiation of cellular transformation like hyperproliferative phenotype, if any. Further studies on different cells are required to understand this interesting phenomenon for the low dose radiation risk assessment.
